2022
DOI: 10.1186/s12884-022-05241-6
|View full text |Cite
|
Sign up to set email alerts
|

A case of discrepancy between three ERA tests in a woman with repeated implantation failure complicated by chronic endometritis

Abstract: Background Endometrial receptivity array (ERA) is used to determine the timing of embryo transfer (ET) synchronized with the window of implantation (WOI). The effectiveness and evaluation of ERAs in women with recurrent implantation failure remain controversial. We report the case of a patient with recurrent implantation failure that raises the issue of reproducibility of ERA tests. Case report A 36-year-old Japanese woman with secondary infertilit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 26 publications
0
5
0
1
Order By: Relevance
“…IVF/ICSI procedures, including ovarian stimulation, oocyte retrieval, and insemination using IVF or ICSI, were performed as previously described [ 39 ]. A frozen–thawed embryo transfer (FET), typically utilizing a hormone replacement cycle, was performed as previously described [ 40 ]. Briefly, an FET was planned, the endometrium was prepared with a hormone replacement cycle, and transdermal estradiol (0.72 mg, Estrana TAPE, Hisamitsu Pharmaceutical, Tokyo, Japan) was started on CD 3.…”
Section: Methodsmentioning
confidence: 99%
“…IVF/ICSI procedures, including ovarian stimulation, oocyte retrieval, and insemination using IVF or ICSI, were performed as previously described [ 39 ]. A frozen–thawed embryo transfer (FET), typically utilizing a hormone replacement cycle, was performed as previously described [ 40 ]. Briefly, an FET was planned, the endometrium was prepared with a hormone replacement cycle, and transdermal estradiol (0.72 mg, Estrana TAPE, Hisamitsu Pharmaceutical, Tokyo, Japan) was started on CD 3.…”
Section: Methodsmentioning
confidence: 99%
“…This suggests that the displacement of the WOI may be dependent on the body mass index. Ota et al [ 21 ] additionally proposed that chronic endometritis could potentially influence WOI displacement.…”
Section: Discussionmentioning
confidence: 99%
“…Although the OPTIMUM treatment strategy did not include endometrial receptivity testing, 25 women underwent ERA (Igenomix Japan, K.K.) or ERPeak SM (CooperSurgical, Inc, United States) in the OPTIMUM group upon their request after CE was not detected given the potential influence CE on the window of implantation 29,30 . Thereafter, personalized ET was performed based on the results.…”
Section: Methodsmentioning
confidence: 99%
“…or ERPeak SM (CooperSurgical, Inc, United States) in the OPTIMUM group upon their request after CE was not detected given the potential influence CE on the window of implantation. 29,30 Thereafter, personalized ET was performed based on the results.…”
Section: Pgt-a and Single Euploid Blastocyst Transfermentioning
confidence: 99%